Forms of apremilast and the process of making the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9765026
APP PUB NO 20170057916A1
SERIAL NO

15246392

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides novel crystalline forms of apremilast hemitoluene solvate, apremilast hydrate, and apremilast anhydrate and an amorphous form of apremilast, and processes for the preparation of these forms.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SCINOPHARM TAIWAN LTDTAIWAN CHINA TAIWAN PROVINCE 000000

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fang, Hsiao-ping Tainan, TW 6 4
Hu, Tsung-Cheng Tainan, TW 15 15
Huang, YuanChang Kaohsiung, TW 5 14
Lin, Yu-Sheng Kaohsiung, TW 179 574
Lo, Wei-Shuo Tainan, TW 5 5
Wang, Kuan Hsun Tainan, TW 2 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 19, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 19, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00